Weeks Douglas L, Sprint Gina L, Stilwill Virgeen, Meisen-Vehrs Amy Lou, Cook Diane J
1 Clinical Research Department, St. Luke's Rehabilitation Institute , Spokane, Washington.
2 Elson S. Floyd College of Medicine, Washington State University , Spokane, Washington.
Telemed J E Health. 2018 Apr 2;24(12):1014-20. doi: 10.1089/tmj.2017.0306.
It is unclear whether wearable heart rate (HR) sensors can be worn continuously in inpatient rehabilitation to assess cardiorespiratory training response. If feasible, these sensors offer a low-cost low-maintenance method for assessing HR response in this setting. We determined feasibility of wearable sensors for assessing HR response to daytime therapy activities in inpatient rehabilitation within a cardiorespiratory training zone equal to 55-80% of maximal HR (target HR [THR]) for at least two 10-min bouts, 3-5 days per week. Secondarily, we determined episodes of excessive HR (EHR >80% of maximal HR).
Subjects 44-80 years of age with diagnoses of stroke, cardiac disorders, orthopedic disorders, medically complex conditions, or pulmonary disorders wore wrist-mounted HR sensors day and night throughout inpatient rehabilitation. The proportion of subjects meeting THR thresholds and experiencing EHR episodes was quantified. Multiple regression predicted THR and EHR outcomes from age, sex, length of stay, and motor function at admission and discharge.
Across subjects, 97,800 min of HR data were analyzed. Sixty percent of subjects met THR thresholds for cardiorespiratory benefit. Age was the single significant predictor of percent of days meeting the THR threshold (R = 0.58, p = 0.024). Forty-seven percent of subjects experienced EHR episodes on at least 1 day. No subjects experienced sensor-related adverse events, and no protocol deviations occurred from inadvertent sensor removal.
Most subjects experienced HR increases sufficient to obtain cardiorespiratory benefit. Likewise, most subjects had episodes of EHR. Wearable sensors were feasible for continuously assessing HR response, suggesting expanded opportunity in inpatient rehabilitation research and treatment.
尚不清楚可穿戴心率(HR)传感器能否在住院康复期间持续佩戴以评估心肺训练反应。如果可行,这些传感器为在此环境下评估心率反应提供了一种低成本、低维护的方法。我们确定了可穿戴传感器在住院康复期间评估白天治疗活动中心率反应的可行性,该心率反应处于等于最大心率(目标心率[THR])55 - 80%的心肺训练区内,每周3 - 5天,每次至少两个10分钟的时段。其次,我们确定了心率过高(EHR>最大心率的80%)的发作情况。
年龄在44 - 80岁、诊断为中风、心脏疾病、骨科疾病、复杂内科疾病或肺部疾病的受试者在整个住院康复期间日夜佩戴腕式心率传感器。对达到THR阈值和经历EHR发作的受试者比例进行了量化。多元回归根据年龄、性别、住院时间以及入院和出院时的运动功能预测THR和EHR结果。
对所有受试者的97,800分钟心率数据进行了分析。60%的受试者达到了心肺获益的THR阈值。年龄是达到THR阈值天数百分比的唯一显著预测因素(R = 0.58,p = 0.024)。47%的受试者至少有1天经历了EHR发作。没有受试者经历与传感器相关的不良事件,也没有因意外移除传感器而出现方案偏差。
大多数受试者的心率升高足以获得心肺获益。同样,大多数受试者有EHR发作情况。可穿戴传感器对于持续评估心率反应是可行的,这表明在住院康复研究和治疗中有更多机会。